Skip to main content
PRO MEDICUS LIMITED logo

PRO MEDICUS LIMITED — Investor Relations & Filings

Ticker · PME ISIN · AU000000PME8 LEI · 98450085A903D1BMFF27 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 864 across all filing types
Latest filing 2024-02-20 Transaction in Own Shar…
Country AU Australia
Listing ASX PME

About PRO MEDICUS LIMITED

https://www.promed.com.au

Pro Medicus Limited provides advanced healthcare imaging software and enterprise-wide IT solutions. The company’s core offering is the Visage 7 platform, which employs server-side rendering technology to enable rapid, high-resolution streaming of medical images, including MRI, CT, and X-ray data. Its product suite encompasses diagnostic viewing, vendor-neutral archiving, and clinical workflow management. Designed for large-scale health systems and academic medical centers, the technology supports cloud-based deployments and integrates artificial intelligence to streamline diagnostic processes. The platform focuses on performance and scalability, allowing clinicians to access and interpret complex imaging datasets from multiple locations without the need for local data transfer.

Recent filings

Filing Released Lang Actions
Update - Notification of buy-back - PME 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is an announcement from PRO MEDICUS LIMITED regarding a daily buy-back notification of its ordinary fully paid shares. It details the number of securities bought back, prices paid, broker information, and dates related to the on-market buy-back program. The content is focused on reporting the ongoing share repurchase activity rather than presenting financial results, management commentary, or regulatory filings. This fits the definition of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back or selling its own shares. The document length and detail confirm it is not a brief announcement or a report publication notice but a substantive update on share repurchase activity.
2024-02-20 English
Notification of cessation of securities - PME 4 pages 14.6KB
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation (cancellation) of 11,300 ordinary fully paid shares of Pro Medicus Limited due to a buy-back. It provides specifics about the securities ceased, the reason for cessation, and the updated issued capital following the change. The document is a formal announcement to the ASX about changes in the company's issued securities. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares. The document length is 3641 characters, which is relatively short but contains substantive details about the share cessation, not just a brief notice or link to a report. Therefore, it is not a Report Publication Announcement or Regulatory Filing. Hence, the classification is POS with high confidence.
2024-02-20 English
Notification of cessation of securities - PME 4 pages 14.6KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cancellation of securities due to a buy-back. It provides specific information about the securities ceased, the number of securities, and the impact on issued capital. The document is a formal announcement to the ASX about changes in the company's securities, specifically cessation due to buy-back. It does not contain financial statements, management discussion, or detailed financial results. It is not a full report but an announcement of a capital change event. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is 3639 characters, which is consistent with an announcement rather than a full report.
2024-02-20 English
Change of Director's Interest Notice - Alice Williams 3 pages 445.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references Listing Rule 3.19A.2, which pertains to disclosure of changes in directors' interests in securities. The content details the acquisition of shares by a director, Alice Williams, including the number of shares before and after the transaction, the nature of the change (on-market purchase), and dates. There is no financial performance data, earnings information, or management discussion. The document is a formal notification of a director's personal share transactions, which fits the definition of 'Director's Dealing' filings. The document length is 4112 characters, which is consistent with a detailed notice rather than a brief announcement or a full report. Therefore, the correct classification is 'DIRS' (Director's Dealing).
2024-02-20 English
Notification of buy-back - PME 5 pages 15.3KB
Transaction in Own Shares Classification · 100% confidence The document is an announcement from Pro Medicus Limited regarding an on-market buy-back of its ordinary fully paid shares. It provides details such as the total number of securities on issue, maximum number of securities to be bought back, broker name, buy-back price, and key dates. The document is relatively short (2323 characters) and focuses solely on the buy-back transaction details without containing financial statements or broader financial performance data. This fits the definition of a Transaction in Own Shares (POS) filing, which reports the company buying back its own shares.
2024-02-19 English
Update - Notification of buy-back - PME 6 pages 18.2KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about the company's on-market buy-back of its own shares, including daily buy-back notifications, number of securities bought back, prices paid, broker details, and dates. It is a regulatory announcement specifically about the company's repurchase of its own shares. This matches the description of 'Transaction in Own Shares' (POS) filings, which report on share repurchases or issuances by the company. The document is not a full financial report, earnings release, or other types of filings. Therefore, the correct classification is POS.
2024-02-19 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.